Our partner is dedicated to developing therapies for rare genetic diseases, with a focus on conditions related to genetic disorders of the immune system. Their innovative treatments aim to address unmet medical needs and improve patient outcomes by targeting the underlying causes of these diseases.

This critical hire led biophysical characterization and functional screening efforts for our partner's growing antibody therapeutics pipeline. This hire also shaped the overall direction of the Bioassays group. They were also responsible for developing, implementing, and managing a broad range of assays in close relationships with various CRO partners.